CIK 0001705843
- Non-accelerated filer
- Smaller reporting company
Cibus, Inc.
Sign in to watch- Ticker
- CBUS
- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 271967997
- Phone
- +1 858-450-0008
- Business address
- 6455 NANCY RIDGE DRIVE, SAN DIEGO, CA, 92121
- Former names
- Calyxt, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 15 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-31 | Blome James Chief Executive Officer | Sale | −4,140 | $4.17 | $17K | 186,282 |
| 2020-09-30 | Blome James Chief Executive Officer | Sale | −4,140 | $5.59 | $23K | 190,422 |
| 2020-08-04 | Blome James Chief Executive Officer | Grant or award · Stock Option (Right-to-Buy) | +175,000 | 175,000 | ||
| 2020-07-01 | Blome James Chief Executive Officer | Sale | −3,495 | $4.65 | $16K | 194,562 |
| 2020-06-29 | Blome James Chief Executive Officer | Sale | −2,902 | $5.01 | $15K | 198,057 |
| 2020-03-31 | Blome James Chief Executive Officer | Shares withheld for taxes | −3,177 | $2.96 | $9K | 200,959 |
| 2019-06-28 | Blome James Chief Executive Officer | Grant or award | +50,000 | 204,136 | ||
| 2019-06-28 | Blome James Chief Executive Officer | Grant or award · Stock Option (Right-to-Buy) | +125,000 | 125,000 | ||
| 2019-06-28 | Blome James Chief Executive Officer | Grant or award · Performance Stock Units | +166,667 | 166,667 | ||
| 2019-04-02 | Blome James Chief Executive Officer | Sale | −2,582 | $16.65 | $43K | 154,136 |
| 2019-03-26 | Blome James Chief Executive Officer | Sale | −2,582 | $17.87 | $46K | 156,718 |
| 2019-03-19 | Blome James Chief Executive Officer | Sale | −2,582 | $17.32 | $45K | 159,300 |
| 2019-03-12 | Blome James Chief Executive Officer | Sale | −2,582 | $16.58 | $43K | 161,882 |
| 2018-10-08 | Blome James Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 |
Page 1 of 1 · 14 trades